• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在未接受抗凝治疗的心房颤动患者中,NT-proBNP 和 GDF-15 与血栓前状态标志物的关系。

Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation.

机构信息

Department of Electrocardiology, The John Paul II Hospital, Kraków, Poland.

Institute of Cardiology, Jagiellonian University Medical College, 80 Prądnicka Street, 31-202, Kraków, Poland.

出版信息

Clin Res Cardiol. 2020 Apr;109(4):426-434. doi: 10.1007/s00392-019-01522-x. Epub 2019 Jul 6.

DOI:10.1007/s00392-019-01522-x
PMID:31280356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7098929/
Abstract

We investigated whether growth differentiation factor-15 (GDF-15), also known as macrophage inhibitory cytokine-1 (MIC-1), levels are associated with a prothrombotic state in atrial fibrillation (AF) as compared to N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin I (cTnI-hs). In 103 patients with AF assessed off anticoagulation (age: 71.0 [65.0-76.0] years; CHADS-VASc score: 4.6 ± 1.7), we measured endogenous thrombin potential (ETP), plasma fibrin clot permeability (K, a measure of clot density) and clot lysis time (CLT) and other hemostatic parameters, along with GDF-15, NT-proBNP, and cTnI-hs. GDF-15 positively correlated with ETP and CLT (r = 0.25, P = 0.01 and R = 0.56, P < 0.0001, respectively) but not with K, von Willebrand factor, thrombin-activatable fibrinolysis inhibitor, plasminogen, antiplasmin or tissue-type plasminogen activator antigen. NT-proBNP showed a stronger association with ETP (r = 0.60, P < 0.0001) and a similar correlation with CLT (R = 0.53, P < 0.0001), while cTnI-hs correlated solely with CLT (R = 0.25, P = 0.01). After adjustment for clinical and laboratory parameters, GDF-15 was a better independent predictor of CLT (unstandardized coefficient B 0.009; 95% confidence interval [CI] 0.006-0.012) than NT-proBNP (B 0.007; 95% CI 0.004-0.010, R (2) = 0.51; P < 0.0001); while among the three biomarkers, only NT-proBNP was an independent predictor of ETP. Elevated GDF-15 and NT-proBNP independently predict impaired fibrin clot lysability, while NT-proBNP is a key predictor of heightened thrombin formation in AF. Our findings suggest that a predictive value of NT-proBNP and GDF-15 in AF could be in part attributed to their association with prothrombotic blood alterations.

摘要

我们研究了生长分化因子-15(GDF-15),也称为巨噬细胞抑制因子-1(MIC-1),在心房颤动(AF)患者中与 N 端脑钠肽前体(NT-proBNP)和高敏心肌肌钙蛋白 I(cTnI-hs)相比,其水平是否与促血栓状态相关。在 103 例接受抗凝治疗的 AF 患者(年龄:71.0[65.0-76.0]岁;CHA2DS2-VASc 评分:4.6±1.7)中,我们测量了内源性凝血酶潜力(ETP)、血浆纤维蛋白凝块通透性(K,反映凝块密度的指标)和凝块溶解时间(CLT)以及其他止血参数,同时还测量了 GDF-15、NT-proBNP 和 cTnI-hs。GDF-15 与 ETP 和 CLT 呈正相关(r=0.25,P=0.01 和 r=0.56,P<0.0001),但与 K、血管性血友病因子、凝血酶激活的纤溶抑制物、纤溶酶原、抗纤溶酶或组织型纤溶酶原激活物抗原无关。NT-proBNP 与 ETP 相关性更强(r=0.60,P<0.0001),与 CLT 相关性相似(r=0.53,P<0.0001),而 cTnI-hs 仅与 CLT 相关(r=0.25,P=0.01)。在调整临床和实验室参数后,GDF-15 是 CLT 的更好独立预测因子(未标准化系数 B 0.009;95%置信区间 [CI] 0.006-0.012),优于 NT-proBNP(B 0.007;95%CI 0.004-0.010,R2=0.51;P<0.0001);而在这三种生物标志物中,只有 NT-proBNP 是 ETP 的独立预测因子。升高的 GDF-15 和 NT-proBNP 独立预测纤维蛋白凝块溶解能力受损,而 NT-proBNP 是 AF 中凝血酶形成增加的关键预测因子。我们的研究结果表明,NT-proBNP 和 GDF-15 在 AF 中的预测价值部分归因于它们与促血栓血液改变的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a2d/7098929/94e7a975b6a3/392_2019_1522_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a2d/7098929/94e7a975b6a3/392_2019_1522_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a2d/7098929/94e7a975b6a3/392_2019_1522_Fig1_HTML.jpg

相似文献

1
Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation.在未接受抗凝治疗的心房颤动患者中,NT-proBNP 和 GDF-15 与血栓前状态标志物的关系。
Clin Res Cardiol. 2020 Apr;109(4):426-434. doi: 10.1007/s00392-019-01522-x. Epub 2019 Jul 6.
2
Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.N末端B型利钠肽原(NT-proBNP)升高与心房颤动时血浆纤维蛋白凝块特性的不良改变有关。
Int J Cardiol. 2017 Sep 15;243:244-250. doi: 10.1016/j.ijcard.2017.05.060. Epub 2017 May 16.
3
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.使用生物标志物评估房颤患者的心力衰竭风险:来自 COMBINE-AF 的分析。
J Am Coll Cardiol. 2024 Oct 15;84(16):1528-1540. doi: 10.1016/j.jacc.2024.07.023. Epub 2024 Sep 2.
4
Prothrombotic plasma fibrin clot phenotype is associated with spontaneous echo contrast in atrial fibrillation: The role of protein carbonylation.促血栓形成的血浆纤维蛋白凝块表型与心房颤动中的自发性回声对比有关:蛋白羰基化的作用。
Thromb Res. 2024 Aug;240:109065. doi: 10.1016/j.thromres.2024.109065. Epub 2024 Jun 17.
5
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.心房颤动对心力衰竭患者 NT-proBNP 与 GDF-15 水平的影响。
Clin Res Cardiol. 2020 Mar;109(3):331-338. doi: 10.1007/s00392-019-01513-y. Epub 2019 Jul 1.
6
Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHADS-VASc Score (Beyond Sex).非瓣膜性心房颤动患者 CHADS-VASc 评分(性别以外)增加一个危险因素时的血栓前状态。
Can J Cardiol. 2019 May;35(5):634-643. doi: 10.1016/j.cjca.2019.01.014. Epub 2019 Jan 30.
7
NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.N末端B型利钠肽原是新发房颤的有力预测指标——多标志物方法的验证
Int J Cardiol. 2016 Nov 15;223:74-81. doi: 10.1016/j.ijcard.2016.08.001. Epub 2016 Aug 4.
8
Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.与房颤发生率相关的室上性心律失常、N 末端脑利钠肽前体和肌钙蛋白 T 浓度:一项前瞻性队列研究。
BMC Cardiovasc Disord. 2021 Mar 12;21(1):134. doi: 10.1186/s12872-021-01942-6.
9
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis.持续性心房颤动中的高敏肌钙蛋白I——与N末端B型利钠肽原以及炎症和止血标志物的关系
Scand J Clin Lab Invest. 2018 Sep;78(5):386-392. doi: 10.1080/00365513.2018.1481224. Epub 2018 Jun 22.
10
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.总 NT-proBNP,一种与复发性心房颤动相关的新型生物标志物。
BMC Cardiovasc Disord. 2021 Nov 19;21(1):553. doi: 10.1186/s12872-021-02358-y.

引用本文的文献

1
Silent cerebral ischemic lesions in ablation-naïve patients with non-valvular atrial fibrillation: Does the pulmonary vein anatomy matter?初治非瓣膜性心房颤动患者的无症状脑缺血性病变:肺静脉解剖结构有影响吗?
Cardiol J. 2025;32(1):35-42. doi: 10.5603/cj.99142. Epub 2024 Nov 26.
2
Predictive value of NT pro BNP for new-onset atrial fibrillation in heart failure and preserved ejection fraction.N末端B型利钠肽原对射血分数保留的心力衰竭患者新发心房颤动的预测价值。
ESC Heart Fail. 2024 Dec;11(6):4296-4307. doi: 10.1002/ehf2.14951. Epub 2024 Aug 28.
3
Sex-based Differences in Heart Failure Biomarkers.

本文引用的文献

1
Biomarkers and Cardiovascular Risk Stratification.生物标志物与心血管风险分层
Eur Heart J. 2019 May 14;40(19):1483-1485. doi: 10.1093/eurheartj/ehz265.
2
Growth differentiation factor 15: A novel biomarker with high clinical potential.生长分化因子 15:一种具有高临床应用潜力的新型生物标志物。
Crit Rev Clin Lab Sci. 2019 Aug;56(5):333-350. doi: 10.1080/10408363.2019.1615034. Epub 2019 May 27.
3
Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHADS-VASc Score (Beyond Sex).非瓣膜性心房颤动患者 CHADS-VASc 评分(性别以外)增加一个危险因素时的血栓前状态。
基于性别的心力衰竭生物标志物差异。
Curr Heart Fail Rep. 2024 Aug;21(4):379-388. doi: 10.1007/s11897-024-00665-x. Epub 2024 May 20.
4
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide.心房颤动伴循环脂多糖升高患者的纤维蛋白溶解功能受损。
J Thromb Thrombolysis. 2024 Jun;57(5):842-851. doi: 10.1007/s11239-024-02980-5. Epub 2024 Apr 21.
5
Growth Differentiation Factor-15 and Clinical Outcomes in Lower Extremity Artery Disease.生长分化因子 15 与下肢动脉疾病的临床转归。
J Atheroscler Thromb. 2024 Jun 1;31(6):964-978. doi: 10.5551/jat.64515. Epub 2024 Jan 31.
6
Development and validation of a risk model for intracardiac thrombosis in patients with dilated cardiomyopathy: a retrospective study.扩张型心肌病患者心腔内血栓形成风险模型的建立与验证:一项回顾性研究。
Sci Rep. 2024 Jan 16;14(1):1431. doi: 10.1038/s41598-024-51745-w.
7
Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion.阵发性或持续性心房颤动患者经体外直流电复律后心房颤动复发的生物标志物
Biomedicines. 2023 May 16;11(5):1452. doi: 10.3390/biomedicines11051452.
8
The association between kidney function, cognitive function, and structural brain abnormalities in community-dwelling individuals aged 50+ is mediated by age and biomarkers of cardiovascular disease.在 50 岁及以上的社区居民中,肾功能、认知功能与结构脑异常之间的关联受到年龄和心血管疾病生物标志物的影响。
Cardiovasc Res. 2023 Sep 5;119(11):2106-2116. doi: 10.1093/cvr/cvad060.
9
Biomarkers in Heart Failure: From Research to Clinical Practice.心力衰竭的生物标志物:从研究到临床实践。
Ann Lab Med. 2023 May 1;43(3):225-236. doi: 10.3343/alm.2023.43.3.225. Epub 2022 Dec 22.
10
Pathogenesis and Management of Brugada Syndrome: Recent Advances and Protocol for Umbrella Reviews of Meta-Analyses in Major Arrhythmic Events Risk Stratification.Brugada综合征的发病机制与管理:重大心律失常事件风险分层中荟萃分析的最新进展及伞状综述方案
J Clin Med. 2022 Mar 30;11(7):1912. doi: 10.3390/jcm11071912.
Can J Cardiol. 2019 May;35(5):634-643. doi: 10.1016/j.cjca.2019.01.014. Epub 2019 Jan 30.
4
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.评估房颤患者发生卒中或全身性栓塞及出血风险的 ABC 评分在 ENGAGE AF-TIMI 48 中的表现。
Circulation. 2019 Feb 5;139(6):760-771. doi: 10.1161/CIRCULATIONAHA.118.038312.
5
The incidence, indications and predictors of acute pacemaker implantation after ablation of persistent atrial fibrillation.持续性心房颤动消融术后急性起搏器植入的发生率、适应证和预测因素。
Clin Res Cardiol. 2019 Jun;108(6):651-659. doi: 10.1007/s00392-018-1393-1. Epub 2018 Nov 20.
6
Antithrombotic medications and their impact on fibrin clot structure and function.抗血栓药物及其对纤维蛋白凝块结构和功能的影响。
J Physiol Pharmacol. 2018 Aug;69(4). doi: 10.26402/jpp.2018.4.02. Epub 2018 Nov 7.
7
Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.肾交感神经去神经术降低心房颤动发生率:AFFORD 研究 12 个月结果。
Clin Res Cardiol. 2019 Jun;108(6):634-642. doi: 10.1007/s00392-018-1391-3. Epub 2018 Nov 10.
8
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.德国心脏病学会细胞电生理学工作组最新论文:分子机制对临床心律失常管理的影响。
Clin Res Cardiol. 2019 Jun;108(6):577-599. doi: 10.1007/s00392-018-1377-1. Epub 2018 Oct 10.
9
Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction.比较心力衰竭患者的生物标志物谱:心房颤动与窦性心律以及射血分数降低与保留。
Eur Heart J. 2018 Nov 14;39(43):3867-3875. doi: 10.1093/eurheartj/ehy421.
10
Association of cardiac troponin I with prothrombotic alterations in atrial fibrillation.心肌肌钙蛋白I与心房颤动中血栓前状态改变的关联
Kardiol Pol. 2018;76(7):1106-1109. doi: 10.5603/KP.2018.0134.